Detalles de la búsqueda
1.
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
Med J Aust;
219(3): 120-126, 2023 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365486
2.
Workforce challenges across Victorian medical oncology services.
Intern Med J;
53(6): 946-950, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571397
3.
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
Intern Med J;
52(8): 1339-1346, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33710759
4.
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer.
Prostate;
81(13): 992-1001, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34254334
5.
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer.
BJU Int;
128 Suppl 1: 18-26, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622543
6.
Victorian Lung Cancer Service Redesign Project: impacts of a quality improvement collaborative on timeliness and management in lung cancer.
Intern Med J;
51(12): 2061-2068, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896957
7.
Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID-19 pandemic.
Intern Med J;
50(10): 1282-1285, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32951279
8.
Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.
Support Care Cancer;
27(2): 373-382, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350189
9.
Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer.
BJU Int;
131(2): 179-182, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371671
10.
Does implementation matter if comprehension is lacking? A qualitative investigation into perceptions of advance care planning in people with cancer.
Support Care Cancer;
26(11): 3765-3771, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29749585
11.
Workforce challenges across Victorian oncology services: author reply.
Intern Med J;
53(6): 1094, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349277
12.
Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
BMC Health Serv Res;
18(1): 147, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29490654
13.
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables.
Oncologist;
20(5): 523-31, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25802406
14.
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.
Cancer Immunol Immunother;
64(4): 507-18, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25662405
15.
Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy.
Support Care Cancer;
22(5): 1233-42, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24337761
16.
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
JCO Oncol Pract;
: OP2400036, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805663
17.
Clinical need for standardised multidisciplinary meeting assessment processes.
Intern Med J;
48(2): 230-231, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29415353
18.
Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.
J Geriatr Oncol;
14(8): 101621, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683368
19.
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Expert Rev Pharmacoecon Outcomes Res;
23(2): 231-239, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541133
20.
Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Br J Cancer;
116(8): e15, 2017 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28324885